Isolating plasma extracellular vesicles from mouse blood using size-exclusion chromatography, density gradient, and ultracentrifugation-Reference-Cited by-同舟云学术

Isolating plasma extracellular vesicles from mouse blood using size-exclusion chromatography, density gradient, and ultracentrifugation

Published:2023-12 Issue:4 Volume:4 Page:102740
ISSN:2666-1667
Container-title:STAR Protocols
language:en
Short-container-title:STAR Protocols

Author:

André-Grégoire Gwennan,Roux Quentin,Gavard Julie^ORCID

Funder

Ligue Contre le Cancer

Centre National de la Recherche Scientifique

Institut National Du Cancer

Conseil Régional des Pays de la Loire

Agence Nationale de la Recherche

Fondation contre le Cancer

Institut National de la Santé et de la Recherche Médicale

Publisher

Elsevier BV

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Reference24 articles.

1. Inhibition of the pseudokinase MLKL alters extracellular vesicle release and reduces tumor growth in glioblastoma;André-Grégoire;iScience,2022

2. Density-Based Fractionation of Cell-Conditioned Medium to Prepare Proteomics Grade Extracellular Vesicles;Roux;Methods Mol. Biol.,2023

3. Preparation of Multi-omics Grade Extracellular Vesicles by Density-Based Fractionation of Urine;Dhondt;STAR Protoc.,2020

4. Robust sequential biophysical fractionation of blood plasma to study variations in the biomolecular landscape of systemically circulating extracellular vesicles across clinical conditions;Vergauwen;J. Extracell. Vesicles,2021

5. Recombinant extracellular vesicles as biological reference material for method development, data normalization and assessment of (pre-)analytical variables;Geeurickx;Nat. Protoc.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on recent advances in exosome isolation and characterization: Toward clinical applications;Translational Oncology;2024-12

2. Protocol for qualitative analysis of lysosome immunoprecipitation from patient-derived glioblastoma stem-like cells;STAR Protocols;2024-06

3. Disease-derived circulating extracellular vesicle preconditioning: A promising strategy for precision mesenchymal stem cell therapy;Acta Pharmaceutica Sinica B;2024-06